Search

everythinglearnresearchcommunity

for

Search:↓

Measuring minimal residual disease on day 15 helps identify high-risk leukemia patients.

The patient's long-term hair loss was caused by leukemia treatments and low estrogen levels, worsened by her genetic tendency for hair loss.

Estrogen and MLL enzymes work together to regulate genes important for hair growth and leukemia.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

Parents manage chemotherapy side effects in children with leukemia using remedies, medication, rest, and dietary adjustments.

CXCL7 is essential for muscle repair by aiding early neutrophil infiltration.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

The oils showed potential to kill certain cancer cells, especially from Dysphania ambrosioides.

Recognizing oral symptoms can help diagnose and treat blood and nutritional diseases early.

Stem cells compete for space using cell adhesion, and mutations can affect their competitive success, with implications for tissue health and disease.

Autoimmune reactions may cause both alopecia areata and HAM.

A woman's sudden hair loss three years after a bone marrow transplant was a sign of chronic graft-versus-host disease but improved with treatment.

The meeting discussed various skin conditions, treatments, and unusual cases, highlighting the effectiveness of tetracycline in treating rosacea.

Certain proteins can either protect against or increase the risk of hypertrophic scars.

Adding Y-27632 and bFGF to the culture medium greatly improves goat hair follicle stem cell growth and quality.

Coenzyme Q10 may protect liver function but doesn't reduce hair loss from anthracycline antibiotics.

An addax had skin cancer that spread to lymph nodes and was euthanized.

Long-standing benign tumors can become cancerous, especially in people with weakened immune systems.

Transit-amplifying cells are crucial for tissue repair and can contribute to cancer when they malfunction.

Non-myeloablative stem cell transplants are a promising, less toxic option for older or weaker patients, with fewer side effects and good outcomes.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

A woman's hair turned gray and fell out after starting a cancer drug called imatinib mesylate.

Nilotinib can cause generalized keratosis pilaris.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Alopecia areata can be transferred through stem cell transplants from affected siblings.

Genomic profiling for myeloid cancers can find important inherited mutations, but it's challenging when these mutations aren't related to the patient's symptoms.

Lymphoma should be considered in unusual scalp hair loss cases, as treatment can work but may lead to severe complications.

Loss of the Y chromosome and UTY gene activity increases cancer risk in men.

Innovative methods are reducing animal testing and improving biomedical research.

Arteannuin might work against cancer and Alzheimer's by targeting neprilysin.